The treatment landscape for many lymphoma entities continues to evolve rapidly, with multiple recent approvals of novel non-chemotherapy (ChT)-based approaches. The following Clinical Practice Guideline (CPG) provides an overview of the current management landscape for the seven most common systemic diseases [i.e. diffuse large B-cell lymphoma (DLBCL), primary central nervous system lymphoma (PCNSL), follicular lymphoma (FL), mantle cell lymphoma (MCL),…
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
Annals of Oncology | | T.A. Eyre, K. Cwynarski, F. d’Amore, L. de Leval, M. Dreyling, D.A. Eichenauer, A.J.M. Ferreri, E. Giné, M.J. Kersten, M. Ladetto, L. Specht, C. Thieblemont, J. Walewski, E. Zucca, M. Jerkeman, ESMO Guidelines Committee
Topics: blood-cancer, chemotherapy, research